Literature DB >> 20407610

Targeting the RB pathway for cancer therapy: peptide mimetic foundations and promise.

Razvan T Radulescu1, Robin Fahraeus.   

Abstract

Entities:  

Year:  2010        PMID： 20407610      PMCID： PMC2855635     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


× No keyword cloud information.
  5 in total

1.  Selective inhibition of human lung cancer cell growth by peptides derived from retinoblastoma protein.

Authors:  R T Radulescu; G Jaques
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

2.  p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth.

Authors:  M Bonfanti; S Taverna; M Salmona; M D'Incalci; M Broggini
Journal:  Cancer Res       Date:  1997-04-15       Impact factor: 12.701

3.  Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.

Authors:  R Fåhraeus; S Laín; K L Ball; D P Lane
Journal:  Oncogene       Date:  1998-02-05       Impact factor: 9.867

4.  From bench to bedside: the growing use of translational research in cancer medicine.

Authors:  Erin M Goldblatt; Wen-Hwa Lee
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

5.  Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines.

Authors:  Eisaku Kondo; Takehiro Tanaka; Takayoshi Miyake; Tomotsugu Ichikawa; Masahiko Hirai; Masaki Adachi; Kazuhiro Yoshikawa; Koichi Ichimura; Nobuya Ohara; Akiyoshi Moriwaki; Isao Date; Ryuzo Ueda; Tadashi Yoshino
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261
  5 in total
  2 in total

1.  Intracellular insulin in human tumors: examples and implications.

Authors:  Razvan T Radulescu
Journal:  Diabetol Metab Syndr       Date:  2011-04-01       Impact factor: 3.320

Review 2.  Perspective on the dynamics of cancer.

Authors:  Youcef Derbal
Journal:  Theor Biol Med Model       Date:  2017-10-03       Impact factor: 2.432
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.